Chengdu Olymvax Biopharmaceuticals Inc.

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

451

Website

www.olymvax.com

Country

China

Exchange

Shanghai

Founded 2009

Chengdu Olymvax Biopharmaceuticals provides the research and development, production, and sales of vaccines for human use in China. The company offers absorbed tetanus vaccine, group a and group c products; and haemophilus influenzae type b products. Founded in 2009, the company is based in Chengdu, China.

Key Stats

52-Week Range

¥19.99¥44.90

Beta0.41

Trailing P/E170.85

Forward P/EN/A

Trailing EPS0.13

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.